RT-PCR AML Panel
Tests
Information
OCTO Health AML Panel utilized for the Real-Time PCR-based identification of translocations t(9;22), inv(16), t(15;17), and t(8;21). Genetic identification of Acute Myeloid Leukemia (AML) plays a crucial role in the treatment process. Specifically, translocations such as t(9;22), inv(16), t(15;17), and t(8;21) are genetic parameters recommended by the WHO for the classification of AML. Genetic recognition of AML is essential for accurate diagnosis and effective management.
